Surging clinical approval of CAR-T cell therapies, expanding gene therapy pipelines, and increasing biopharmaceutical investment are driving rapid expansion across the global Cell and Gene Therapy Biomanufacturing Market. Valued for its ability to produce live cellular products and viral vectors under strict sterile conditions, CGT biomanufacturing relies heavily on high-containment cleanrooms,...